Loading clinical trials...
Loading clinical trials...
Evaluation of Endothelial Dysfunction Using the "Flow Mediated Dilation" Test in a Population of Chronic Renal Failure Patients at Different Stages, and Evaluation of the Role of Antiphospholipid Antibodies - A Prospective Interventional Study.
Conditions
Interventions
Urine sampling
Blood sampling
+1 more
Locations
1
Belgium
Brugmann University Hospital
Brussels, Belgium
Start Date
October 17, 2023
Primary Completion Date
December 31, 2024
Completion Date
December 31, 2024
Last Updated
April 4, 2024
NCT06227468
NCT05353946
NCT01604395
NCT07390604
NCT07337083
NCT04700631
Lead Sponsor
Brugmann University Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions